 - Use of an investigational drug within 28 days or 5 half-lives whichever is shorter prior to the first dose of study drug. A minimum of 10 days between termination of the investigational drug and administration of the study treatment is required. In addition, any drug-related toxicity except alopecia should have recovered to grade 1 or less. 